Prevention of cachexia-like syndrome development and reduction of tumor progression in inhibin-deficient mice following administration of a chimeric activin receptor type II-murine Fc protein.

Source:http://linkedlifedata.com/resource/pubmed/id/17704537

Download in:

View as

General Info

PMID
17704537